Case study in Clinical trials
Safety and suitability of an infant formula in healthy term infants See all the case studiesGet in touchKey information
Main study endpoints
Safety: growth parameters, adverse events
Population
360 babies
Tested product
Infant formula manufactured from extensively hydrolysed protein
Investigations
21 sites around the world
key challenge
– 360 infants included in less than 2 months
– This study has been completed in only one year